A common liver condition — non-alcoholic fatty liver disease — is in the midst of a rebrand. Why it matters: The name of the condition, which affects 1 in 4 U.S. adults, was officially changed ...
A New 3D Bioprinted Model Offers a Novel Tool to Study Common Liver Disease, and Perhaps Find an Effective Treatment Jan. 23, 2024 — Metabolic dysfunction--associated steatohepatitis or MASH ...
Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...